Protective effects of the lazaroid U-74389G against hyperoxia in rat type II pneumocytes

Pulmonary Pharmacology and Therapeutics

Volumn 11, Issue 1, 1998, Pages 23-30

  Van Klaveren, R J ^a   Roelant, C ^a   Boogaerts, M ^a   Pype, J L ^a   Demedts, M ^a   Nemery, B ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Chemiluminescence; Lazaroids; Lipid peroxidation; Nitric oxide synthase; Superoxide anion

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; HYDROGEN PEROXIDE; LAZAROID; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; OXYGEN RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPEROXIA; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032004068     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1998.0114     Document Type: Article

References (34)

1. 1. Kinnula VL, Chang LY, Ho YS, Crapo JD. Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo. Exp Lung Res 1992; 18: 655-673.
2. 2. Sanders SP, Zweier JL, Kuppusamy P, Harrison SJ, Bassett DJP, Gabrielson EW, Sylvester JT. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J Clin Invest 1993; 91: 46-52.
3. 3. Ischiropoulos H, Nadziejko CE, Kumae T, Kikkawa Y. Oxygen tolerance in neonatal rats: role of subcellular superoxide generation. Am J Physiol 1989; 257: L411-L420.
4. 4. Aerts C, Wallaert B, Voisin C. In vitro effects of hyperoxia on alveolar type II pneumocytes: inhibition of glutathione synthesis increases hyperoxic cell injury. Exp Lung Res 1992; 18: 845-861.
5. 5. Kennedy KA, Crouch LS, Warshaw JB. Effect of hyperoxia on antioxidants in neonatal rat type II cells in vitro and in vivo. Pediatric Res 1989; 26: 400-403.
6. 6. Crapo JD, McCord JM. Oxygen-induced changes in pulmonary superoxide dismutase assayed by antibody titrations. Am J Physiol 1976; 231: 1196-1203.
7. 7. Freeman BA, Mason RJ, Williams MC, Crapo JD. Antioxidant enzyme activity in alveolar type II cells after exposure of rats to hyperoxia. Exp Lung Res 1986; 10: 203-222.
8. 8. Gutierrez HH, Pitt BR, Schwarz M, Watkins SC, Lowenstein C, Caaniggia I, Chumley P, Freeman BA. Pulmonary alveolar epithelial inducible NO syntase gene expression: regulation by inflammatory mediators. Am J Physiol 1995; 268: L501-L508.
9. 9. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker-Botelho LH. Cytoprotective function of nitric oxide. Biochem Biophys Res Comm 1991; 181: 1392-1397.
10. -.. Free Radical Res Commun 1993; 18: 195-199.
11. 11. Harbrecht BG, Billiar TR, Stadler J. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992; 20: 1568-1574.
12. 12. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815-820.
13. 13. Kubes P, Suzuki M, Granger DM. Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
14. 14. MacKendrick W, Kaplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993; 34: 222-228.
15. 15. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725.
16. 16. Clancy RM, Leszcynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxing factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116-1121.
17. 17. Rengasamy A, Johns RA. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions. J Pharmacol Exper Ther 1991; 259: 310-316.
18. 18. Punjabi CJ, Laskin JD, Pendino KJ, Goller NL, Durham SK, Laskin DL. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol 1994; 11: 165-172.
19. 19. Warner RL, Paine R, Christensen PJ, Marletta MA, Richards MK, Wilcoxen SE, Ward PA. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12: 649-661.
20. 20. Haynes J, Seibert A, Bass JB, Taylor AE. U74500A inhibition of oxidant-mediated lung injury. Am J Physiol 1990; 259: H144-H148.
21. 21. Tanigaki T, Suzuki Y, Heimer D, Sussman HH, Ross WG, Raffin TA. Attenuation of acute lung injury and oxygen radical production by the 21-aminosteroid, U-78518F. J Appl Physiol 1993; 74: 2155-2160.
22. 22. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262: 10438-10440.
23. 23. Braughler JM, Chase RL, Neff GL. A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells. J Pharmacol Exp Ther 1988; 244: 423-427.
24. 24. Richards RJ, Davies N, Atkins J, Oreffo VIC. Isolation, biochemical characterization and culture of lung epithelial type II cells of the rat. Lung 1987; 165: 143-158.
25. 25. Hoet PHM, Lewis CPL, Demedts M, Nemery B. Putrescine and paraquat uptake in human lung slices and isolated type II pneumocytes. Biochem Pharmacol 1994; 48: 517-524.
26. 26. van Klaveren RJ, Hoet PHM, Pype JL, Demedts M, Nemery B. Increase in γ-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Rad Biol Med 1997; 22: 525-534.
27. 27. Allen RC. Phagocyte leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis. Methods Enzymol 1986; 133: 449-493.
28. 28. Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
29. 15N) nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
30. 30. Brawn MK, Chiou WJ, Leach KL. Oxidant-induced activation of protein kinase C in UC11MG cells. Free Rad Res 1995; 22: 23-37.
31. 31. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform-extraction. Anal Biochem 1980; 106: 156-159.
32. 32. Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induces NF-κB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Comm 1994; 199: 1518-1524.
33. 33. Bedoya FJ, Flodström M, Eizirik DL. Pyrrolidine dithiocarbamate prevents IL-1 induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochem Biophys Res Comm 1995; 210: 816-822.
34. 34. Hecker M, Press C, Schini-Kerth VB, Busse R. Antioxidants differentially affect nuclear factor-κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Letters 1996; 380: 224-228.